Navigation Links
Lutonix Announces Achievement of Significant Milestones and Additions to Executive Leadership Team
Date:6/28/2011

MINNEAPOLIS, June 28, 2011 /PRNewswire/ -- Lutonix today announced receiving approval from the US Food and Drug Administration to begin enrollment in its LEVANT 2 IDE clinical trial for the treatment of peripheral arterial disease (PAD), along with receipt of CE Mark for its drug-coated balloon and ISO certification.  Lutonix is the first company to receive approval from the FDA to initiate a drug-coated balloon trial.  

The company also announced two new additions to its leadership team.  Shawn McCormick was named Chief Operating Officer and will oversee manufacturing, R&D, finance and administration for the company.  Leslie Trigg was named Executive Vice President, Marketing and Commercial Strategy and will oversee all commercialization aspects of the business.

LEVANT 2 Trial Set to Begin

LEVANT 2 is a global, multicenter, randomized study evaluating the safety and efficacy of the Moxy™ Drug Coated Balloon compared to a standard angioplasty balloon for treating diseased leg arteries above the knee.  The trial is designed to support an application to the US FDA for approval of the Moxy balloon.  Co-principal investigators for this international study are Dr. Ken Rosenfield (Massachusetts General Hospital, Boston MA) and Dr. Dierk Scheinert (University of Leipzig, Leipzig Germany).

The LEVANT 2 trial was preceded by LEVANT 1, a multi-center, prospective randomized trial of 101 patients with PAD.  In this study, the Moxy balloon was compared to standard angioplasty.  Data presented during the 2010 Transcatheter Cardiovascular Therapeutics meeting showed that the Moxy balloon had the ability to safely and substantially inhibit restenosis.

"Finding a durable treatment for PAD has proven to be one our most difficult clinical challenges," said Dr. Rosenfield.  "PAD patients are in great need of better treatment options.  This trial is an important step forward
'/>"/>

SOURCE Lutonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lutonix Inc. Announces $20 Million Series B Financing
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "Micro Market Monitor: ... to their offering. ... treatment is progressing steadily, which has resulted in ... devices market. The main purpose of these dermatology ...
(Date:12/19/2014)... , Dec. 18, 2014 Baptist Health Lexington is ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) ... Atrial fibrillation is the most common cardiac arrhythmia ... some cases can lead to stroke and possible death. More ... have atrial fibrillation and the numbers are rapidly ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
Breaking Medicine Technology:Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... VPHM ) today announced that Vincent Milano, president ... Citi 2011 Global Healthcare Conference at 2:00 P.M. ET on ... the Hilton New York Hotel in New York City. ... ViroPharma, will present at the Cowen & Company 31st Annual ...
... ANGELES, Feb. 28, 2011 InstaCare Corp. (OTC Bulletin ... of direct to patient diabetes programs, a leading provider ... ill, and a leading developer of revolutionary cell phone ... Thursday, February 24, 2011, the Company filed a utility ...
Cached Medicine Technology:ViroPharma to Participate in Two March Healthcare Conferences 2InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 2InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 3
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Potentially illness-causing ... herbs bought at farmers markets, according to a new ... almost 50 vendors from 13 farmers markets in Los ... Seattle area. Out of almost 150 samples tested, 24 ... positive for salmonella, according to the researchers. Both ...
(Date:12/19/2014)... of bacteria called biofilms can be found on most colon ... researchers said these biofilms were especially prevalent on the right ... may represent an increased likelihood of colon cancer and could ... the disease, the researchers said. Like tooth plaque and ... layer of cells lining the colon, according to background information ...
(Date:12/19/2014)... adults who have lost all their teeth have faster decreases ... at least some of their teeth, a new study says. ... an early warning of increased risk of physical and mental ... the findings don,t prove that tooth loss causes the physical ... participants 60 and older. People with no remaining teeth did ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Diet Doc ... date, current approach to weight loss by ... understanding. The professionals at the company understand that remaining ... side effects of eliminating carbohydrates and sugars from the ... tempted to abandon their weight loss goals. , ...
(Date:12/19/2014)... 19, 2014 B. E. Smith, the ... providers, has been retained to lead a national ... Center in Estes Park, Colo. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... 25-bed, not-for-profit critical access hospital and level IV trauma ...
Breaking Medicine News(10 mins):Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 3Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 4Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3
... Around one of every three children is chronically malnourished ... the poorest country in the Western Hemisphere.// Some typical ... and dull eyes. ,Patricia A. Wolff, M.D., ... of Medicine in St. Louis decided to do something ...
... may influence a woman’s risk of having cervical cancer from ... Xi, at the University of Washington in Seattle, US, and ... to HPV revealed that a variant of the HPV from ... her ancestors come from the same region. ,HPV ...
... vaccine producer, has been awarded a tender to import the ... ,The Agricultural Ministry awarded the tender to the company, ... was the lowest among the bidding companies. The company ... begin within two weeks after the receipt of the letter ...
... recently learnt that she is expecting conjoined twin girls. Felicia Simms ... pregnancy// and the attention she's getting because of it. ... who are joined at the scalp. ,She said, ‘I ... keeping these babies healthy and me healthy and making sure they ...
... on August 3, 2006, by researchers from Michigan State University ... physically more active show better academic performance than those who ... Medicine has published the findings of this research in the ... Sports & Exercise. ,In this study, more than ...
... McMaster University including proteins in the sports drink and ... play an important role in providing energy as it ... muscles, and sodium maintains fluid balance in the body. ... of Medicine & Science in Sports & Exercise, found ...
Cached Medicine News:Health News:Crusade Against Malnutrition 2Health News:Crusade Against Malnutrition 3Health News:Race May Influences Cancer Risk From HPV 2Health News:Woman Pregnant with Conjoined Twins 2Health News:Physical Activity Determines Academic Performance 2Health News:Is Addition Of Proteins In The Sports Drink Beneficial? 2
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit in-TDT Calibrators and Controls...
PT-HS with Calcium - 2 ml...
Medicine Products: